Accredited official statistics

PHE MRSA, MSSA, Gram-negative bacteraemia and CDI: quarterly report

Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.

• From: Public Health England
• Published: 12 June 2014
• Last updated: 8 July 2021 — See all updates

Documents

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2021)

Ref: GOV-8841

PDF, 1.91 MB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to January to March 2021)

Ref: PHE publications gateway number: GOV-8841

ODS, 45.2 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to October to December 2020)

Ref: PHE Publications Gateway No: GOV-7869

PDF, 1.31 MB, 24 pages

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to October to December 2020)

Ref: PHE Publications Gateway No: GOV-7869

MS Excel Spreadsheet, 48 KB

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2020

https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view_file/448573294

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to July to September 2020)

Ref: PHE gateway number: GW-1768

PDF, 1.19 MB, 25 pages

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to July to September 2020)

ODS, 47.2 KB

This file is in an OpenDocument format

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, July to September 2020

https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view_file/448592758

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to April to June 2020)

Ref: PHE gateway number: GW - 1537

PDF, 512 KB, 25 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to April to June 2020)

MS Excel Spreadsheet, 45.8 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2020

https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view_file/448573360

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2020)

Ref: PHE gateway number: GW - 1320

PDF, 708 KB, 23 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to January to March 2020)

ODS, 50.1 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2020

https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view_file/448573545

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to October to December 2019)

Ref: PHE gateway number: GW -1155

PDF, 696 KB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to October to December 2019)

ODS, 44.9 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2019

https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view_file/448573702

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to July to September 2019)

Ref: PHE gateway number: GW-957

PDF, 645 KB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to July to September 2019)

ODS, 41.8 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, July to September 2019

https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view_file/448574553

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to April to June 2019)

Ref: PHE gateway number: GW-713

PDF, 725 KB, 34 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to April to June 2019)

ODS, 44.1 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2019

https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view_file/448592729

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2019)

Ref: PHE gateway number: GW-469

PDF, 1.6 MB, 34 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to January to March 2019)

ODS, 45.4 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2019

https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view_file/448573936

Details

From September 2017

The commentaries contain national aggregated data and an overview of the trends in the mandatory reports of HCAI; meticillin resistant Staphylococcus aureus (MRSA), meticillin susceptible Staphylococcus aureus (MSSA) and Gram-negative bacteraemia and Clostridioides difficile (C. difficile) infection, over recent quarters.

For previous quarterly commentaries and associated data please see:

• June 2018 to March 2019

• September 2013 to March 2018

Older quarterly commentaries and associated data are also available from the UK Government Web Archive.

Published 12 June 2014
Last updated 8 July 2021 + show all updates

1. 8 July 2021

   Added January to March 2021 quarterly epidemiological commentary and accompanying data.

2. 8 April 2021

   Added October to December 2020 quarterly epidemiological commentary and accompanying data.

3. 10 December 2020

   Added commentary and accompanying data spreadsheet for July to September 2020.

4. 10 September 2020

   Added commentary and accompanying data spreadsheet for April to June 2020.

5. 11 June 2020

   Added commentary and accompanying data spreadsheet for January to March 2020.

6. 12 March 2020

   Added commentary and accompanying data spreadsheet, for October to December 2019.

7. 13 December 2019

   Added commentary and accompanying data spreadsheet, for quarter July to September 2019.

8. 12 September 2019

   Added commentary and accompanying data spreadsheet, for April to June 2019; archived quarterly commentaries from June 2018 to March 2019.

9. 3 July 2019

   Added amended commentary for quarter January to March 2019 due to a data mismatch in figure 2.

10. 13 June 2019

    Added commentary and accompanying data spreadsheet, for quarter January to March 2019.

11. 14 March 2019

    Added commentary and accompanying data spreadsheet, for quarter October to December 2018.

12. 13 December 2018

    Added commentary and accompanying data spreadsheet, for quarter July to September 2018.

13. 13 September 2018

    Added commentary and accompanying data spreadsheet, for quarter April to June 2018; archived quarterly commentaries from June 2017 to March 2018.

14. 20 July 2018

    Added amended commentary and accompanying data spreadsheet, for quarter January to March 2018; due to corrected CDI data for quarter 3 financial year April 2007 to March 2008.

15. 14 June 2018

    Added commentary and accompanying data spreadsheet, for quarter January to March 2018; archived quarterly commentaries from 2013 to 2016.

16. 8 March 2018

    Added commentary and accompanying data spreadsheet for October to December 2017.

17. 14 December 2017

    Quarterly epidemiological commentary (up to July to September 2017).

18. 14 September 2017

    Added commentary and accompanying data spreadsheet, for quarter April to June 2017.

19. 8 June 2017

    Added commentary and accompanying data spreadsheet, for quarter January to March 2017.

20. 9 March 2017

    Added commentary and accompanying data spreadsheet, for quarter October to December 2016.

21. 8 December 2016

    Added commentary and accompanying data spreadsheet, for quarter July to September 2016.

22. 8 September 2016

    Added commentary and accompanying data spreadsheet, for quarter April to June 2016.

23. 9 June 2016

    Added commentary and accompanying data spreadsheet, for quarter January to March 2016.

24. 10 March 2016

    Added commentary for data, for quarter October to December 2015.

25. 10 December 2015

    Added commentary for data, July to September 2015.

26. 10 September 2015

    Added commentary for data, April to June 2015.

27. 11 June 2015

    Added commentary for data up to January to March 2015.

28. 12 March 2015

    Added commentary for data up to October to December 2014.

29. 11 December 2014

    Added commentary for data up to July to September 2014.

30. 19 September 2014

    Added commentary for data up to April to June 2014.

31. 12 June 2014

    First published.